Global eClinical Solution Market is valued at USD 8.12 Billion in 2021 and is expected to reach USD 19.69 Million by 2028 with a CAGR of 13.5% over the forecast period.
Global eClinical Solution Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028- Increasing demand for eClinical solutions, rising integration of software solutions in clinical trials, and growing various technological advancements and improvements are some of the major factors driving the growth of the Global eClinical Solution Market.
eClinical solutions are software and applications for efficient management of clinical trials and clinical research. Under the umbrella of e-Clinical Solutions, different software helps to manage, monitor, and record data as well as track deadlines with other features. Various eClinical measures include randomization and test supply management (RTSM), clinical trial management system (CTMS), and clinical data management system (CDMS). eClinical Solutions manage clinical technologies and skills to accelerate the clinical development process. eClinical solutions can be operated by web-based applications, installed on-premises, or deployed through cloud-based platforms. These measures validate and analyse clinical and operational data through integrated and advanced visualization and analytical techniques. As a result, they are widely used in hospitals, clinics, diagnostic centers, and other healthcare institutions.
|2018 - 2021
|2022 - 2028
|Market Size in 2021:
|USD 8.12 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2028:
|USD 19.69 Billion
|Tables, Charts & Figures:
|eClinical Solution Companies
|Datatrak International, Inc., eClinical Solutions, IBM Watson Health, ERT Clinical, Bioclinica, Parexel International Corporation, Oracle, Dassault Systems, Anju Life Sciences Software, CRF Health, eClinicalWorks, and others.
|By Product, By Mode of Delivery, By End-User
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
The Covid-19 pandemic has shown a positive impact on the growth of the global eClinical solution market. During Covid-19 pandemic, number of biotechnological and pharmaceutical companies have focused their research and development efforts on supporting the development of the Covid-19 vaccine. Furthermore, due to the pandemic, many clinical trials adopted fully virtual/hybrid models, which significantly increased the demand for eClinical solutions.
Some major key players for the global eClinical solution market report cover prominent players like Datatrak International, Inc., eClinical Solutions, IBM Watson Health, ERT Clinical, Bioclinica, Parexel International Corporation, Oracle, Dassault Systems, Anju Life Sciences Software, CRF Health, eClinicalWorks, and others.
eClinical Solutions Launched Elluminate Clinical Trial Management System (CTMS) for Faster Drug Development
On February 1st, 2021; eClinical Solutions LLC announced the launch of the Illuminati Clinical Trial Management System (CTMS). Built on the Illuminate platform, which accelerates digitization and shortens clinical data review cycle times, the Illuminate CTMS now provides a source of truth for clinical operations data for faster and more informed decision making.
Oracle Launched a New Cloud-Based eClinical Solution
On February 9th, 2018; Oracle announced the launch of a new comprehensive, unified cloud-based clinical solution aimed at bringing new drugs to market on time while maintaining quality and safety. The new """"Clinical One Platform"""" will combine clinical development operations and information with functions shared into a single environment and with an easy-to-use interface for sites, clinical coordinators, and their counterparts.
One of the major factors driving the growth of the eClinical solution market is the increasing number of clinical trials in the pharmaceuticals and biotechnology industries. Pharmaceutical and biotechnological organizations use eClinical measures to obtain regulatory approvals for newly developed drugs and medicines. The rising use of eClinical solutions in hospitals, medical device manufacturers, academic research institutions, consulting service companies, contract research organizations, and others is expected to drive the growth of the market. For instance; according to U.S. National Library of Medicine, there are about 417,550 clinical trials studies, including locations in all 50 states and 220 countries. As of March 2021, ClinicalTrials.gov received approximately 4.5 million monthly visitors.
In addition, the rising usage of eClinical solutions by CROs is also boosting the market growth. In order to reduce R&D costs by pharma and biotech companies, the increasing demand for outsourcing of clinical trials on various CROs will further drive the departmental growth, which will complement the market. Furthermore, clinical data management systems (CDMS) and electronic data capture (EDC) are the most prominent eClinical solutions adopted by various CROs to manage rising data volume. For instance; as per the news published, on February 2nd, 2022; Castor launched CRO partnership program to increase the adoption of decentralized clinical trials. Moreover, the growing focus on R & D activities is another factor boosting the market growth. Developing a new drug is a long and complicated process, with the risk of failure at each stage. R & D From basic science to preclinical and clinical research to the approval of new treatments for patients is shared in a strong R & D ecosystem by industry, government, educational institutions and all other supplements play important role in bringing new medical advances to patients.
However, the high maintenance and implementation cost associated with eClinical solutions may hamper the growth of the global eClinical solution market. In spite of that, rising R&D for precision medicine may create more opportunities for the further growth of the market.
North America Holds a Major Share in the Global eClinical Solution Market
Geographically, North America is expected to dominate the global eClinical solution market within the forecast period due to the increasing prevalence of diabetes, rising clinical research activities, and the growing number of target populations in this region. The increasing prevalence of lifestyle-associated diseases such as diabetes and cardiac disorders are also boosting the market growth. For instance; according to the centers for disease control and prevention; in 2020, about 34.2 million people had diabetes in the United States. Rising clinical research activities also drives the market in this region. The rising clinical research activities have increased the demand for the eClinical solution market. For instance, as per the news published, on March 14th, 2022; National Institutes of Health (NIH) has launched Phase 1 clinical trials evaluating three experimental HIV vaccines based on the Messenger RNA (mRNA) platform. The technology is used in a number of recognized Covid-19 vaccines.
The Asia Pacific is the fastest-growing region in the global eClinical solution market due to the increasing incidence of targeting chronic diseases such as cardiovascular conditions, cancer, & infectious diseases and maintaining outsourcing of clinical trials in this region. The increasing incidences of targeting chronic diseases such as cardiovascular conditions, cancer, and infectious diseases are also boosting the market growth. For instance; according to the Times of India, on January 7th, 2021; there are about 75 million people over the age of 60 in India suffer from some form of chronic illness.
By Mode of Delivery
The Middle East and Africa
By Mode of Delivery
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®